Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion type Assertion NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_head.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion description "[Genetic polymorphisms in genes related to metabolism and action sites of gemcitabine showed associations with the therapeutic efficacy, in terms of OS, TTP and disease progression in pancreatic cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_provenance.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion evidence source_evidence_literature NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_provenance.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion SIO_000772 22838950 NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_provenance.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion wasDerivedFrom befree-20140225 NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_provenance.
- NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_assertion wasGeneratedBy ECO_0000203 NP429419.RAUP8xuc5JHyo8FNQ8JP4f1eT3Haqb0QSwTiIimUgT9tg130_provenance.